Targeting the $5 BILLION Soft Tissue Repair Market

Chitogenx is in the regulatory lead for regenerative products + signs MOU with major Medical Institute

Free
Message: SmallCap 60: Ortho Regenerative (ORTH: CSE) (ORTIF: OTCQB) Is Happy With Speed and Process of Clinical Trial Sites

SmallCap 60: Ortho Regenerative (ORTH: CSE) (ORTIF: OTCQB) Is Happy With Speed and Process of Clinical Trial Sites

posted on Jun 24, 2022 02:41PM

Share
New Message
Please login to post a reply